129
Views
5
CrossRef citations to date
0
Altmetric
Articles

Effects of pentoxifylline on hemodynamic, hemorheological, and microcirculatory parameters in young SHRs during arterial hypertension development

, , , , , , & show all
Pages 570-578 | Received 02 Jan 2017, Accepted 30 Jan 2017, Published online: 19 Jul 2017

References

  • Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747—1757.
  • Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–74.
  • Sundström J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: Cohort study of Swedish male conscripts. BMJ 2011;342:d643.
  • Hayman LL, Meininger JC, Daniels SR, et al. Primary prevention of cardiovascular disease in nursing practice: Focus on children and youth: A scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007;116:344–57.
  • Mancia G, Fagard R, Narkiewicz K, et al. Task force members. ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–357.
  • Bertovic DA, Waddell TK, Gatzka CD, et al. Muscular strength training is associated with low arterial compliance and high pulse pressure. Hypertension 1999;33:1385–91.
  • Chien S. Blood rheology in myocardial infarction and hypertension. Biorheology 1986;23:633–53.
  • Letcher R, Chien S, Pickering T, et al. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 1981;70:1195–202.
  • Devereux RB, Drayer JI, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984;54:592–95.
  • Lominadze D, Joshua I, Schuschke D. Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 1998;11:784—789.
  • Müller R. Hemorheology and peripheral vascular diseases: A new therapeutic approach. J Med 1981;12:209–35.
  • Schmid-Schönbein H. Blood rheology and physiology of microcirculation. Ric Clin Lab 1981;11(Suppl 1):13–33.
  • Muravyov AV, Bulaeva SV, Tikhomirova IA, et al. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: The molecular change mechanisms after pentoxifylline treatment. Clin Hemorheol Microcirc 2011;49:431–39.
  • Bacher A, Eggensperger E, Koppensteiner R, et al. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion. Acta Anaesthesiol Scand 2005;49:41–46.
  • Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50–97.
  • Azhar A, El-Bassossy HM. Pentoxifylline alleviates hypertension in metabolic syndrome: Effect on low-grade inflammation and angiotensin system. J Endocrinol Invest 2015;38:437–45.
  • Guggilam A, Haque M, Kerut EK, et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 2007;293:H599–609.
  • Mayyas F, Alzoubi KH, Al-Taleb Z. An evaluation of the effect of pentoxifylline on blood pressure and myocardial oxidative status following intake of western diet. Clin Exp Hypertens 2015;37:666–73.
  • Patent RU 2239423. Haemorheological and antiplatelet medicine. http://www1.fips.ru/fips_servl/fips_servlet?DB=RUPAT&rn=3340&DocNumber=2239423&TypeFile=html.
  • Dettelbach HR, Aviado DM. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 1985;25:8–26.
  • Murav’ev AV, Iakusevich VV, Zamyshliaev AV, et al. Analysis of rheological changes in blood based on a haemorheologic profile concept. Klin Lab Diagn 2001;7:43–45.
  • Muravyov AV, Tikhomirova IA, Maimistova AA, et al. Red blood cell aggregation changes are depended on its initial value: Effect of long-term drug treatment and short-term cell incubation with drug. Clin Hemorheol Microcirc 2011;48:231–40.
  • Shin S, Hou JX, Suh JS, Singh M. Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability. Clin Hemorheol Microcirc 2007;37:319–28.
  • Francois-Dainville E, Buchweitz E, Weiss HR. Effect of hypoxia on percent of arteriolar and capillary beds perfused in the rat brain. J Appl Physiol 1986;60:280–88.
  • Dornas WC, Silva ME. Animal models for the study of arterial hypertension. J Biosci 2011;36:731—737.
  • Plotnikov MB, Aliev OI, Anishchenko AM, et al. Dynamics of blood pressure and quantity indices of erythrocytes in SHR in early period of arterial hypertension forming. Ross Fiziol Zh Im I M Sechenova 2015;101:822–28. ( Article in Russian).
  • Zicha J, Kunes J. Ontogenetic aspects of hypertension development: Analysis in the rat. Physiol Rev 1999;79:1227–82.
  • Sagie A, Larson MG, Levy D. The natural history of border line isolated systolic hypertension. Engl J Med 1993;329:1912–17.
  • Plotnikov MB, Aliev OI, Anishchenko AM, et al. Sequence of changes in viscosity of whole blood, blood pressure, and vasodilator function of endothelium in spontaneously hypertensive rats at the formation stage of hypertension. Biorheology 2015;52:141.
  • Anishchenko AM, Aliev OI, Sidekhmenova AV, et al. Dynamics of blood pressure elevation and endothelial dysfunction in SHR rats during the development of arterial hypertension. Bull Exp Biol Med 2015;159:591–93.
  • Paiardi S, Rodella LF, De Ciuceis C, et al. Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc 2009;42:259–68.
  • Bachmanov AA, Maslennikova LS, Markova LA. Changes in oxygen metabolism during active avoidance learning in spontaneously hypertensive and normotensive rats. Fiziol Zh SSSR Im I M Sechenova 1991;77:35–40. ( Article in Russian).
  • Plotnikov MB, Aliev OI, Koltunov AA, Maslov M. Increased blood viscosity syndrome in SHR rats: analysis of the model adequacy. Biull Eksp Biol Med 1998;126:150–52. Article in Russian.
  • Bruschi G, Minari M, Bruschi ME, et al. Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertens 1986;8:983–89.
  • Ariyoshi K, Maruyama T, Odashiro K, et al. Impaired erythrocyte filterability of spontaneously hypertensive rats: investigation by nickel filtration technique. Circ J 2010;74:129–36.
  • Paniagua O, Bryant M, Panza J. Role of endothelial nitric oxide on shear stress-induced vasodilation of human microvasculature. Circulation 2001;103:1752–58.
  • Gómez-Roso M, Montero MJ, Carrón R, Sevilla MA. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril. Br J Pharmacol 2009;158:1911–21.
  • Plotnikov MB, Aliev OI, Nosarev AV, et al. Relationship between arterial blood pressure and blood viscosity in spontaneously hypertensive rats treated with pentoxifylline. Biorheology 2016;53:93–107.
  • Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003;108:2054–59.
  • Salazar Vázquez BY, Martini J, Chávez Negrete A, et al. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: Experimental and clinical evidence. Clin Hemorheol Microcirc 2010;44:75–85.
  • Muravyov AV, Yakusevich VV, Chuchkanov FA, et al. Haemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: In vitro study. Clin Hemorheol Microcirc 2007;36:327–34.
  • Aviado DM, Dettelbach HR. Pharmacology of pentoxifylline, a haemorheologic agent for the treatment of intermittent claudication. Angiology 1984;35:407–17.
  • Ott E, Körner E, Lechner H. Haemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline – a prospective study. Angiology 1988;39:520–25.
  • McCarty MF, O’Keefe JH, DiNicolantonio JJ. Pentoxifylline for vascular health: a brief review of the literature. Open Heart 2016;3:e000365.
  • Banfi C, Sironi L, De Simoni G, et al. Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats. J Pharmacol Exp Ther 2004;310:890–95.
  • Mchedlishvili G, Tsinamdzvrihvili B, Momtselidze N, Beritashvili N. Kinetics of beneficial effect of pentoxifylline on persistent forms of arterial hypertension. Clin Hemorheol Microcirc 1998;18:285–90.
  • Harmankaya O, Seber S, Yilmaz M. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients. Ren Fail 2003;25:465–70.
  • Zhang X, Meng F, Song J, et al. Pentoxifylline ameliorates cardiac fibrosis, pathological hypertrophy, and cardiac dysfunction in angiotensin II-induced hypertensive rats. J Cardiovasc Pharmacol 2016;67:76–85.
  • Vázquez BY. Blood pressure and blood viscosity are not correlated in normal healthy subjects. Vasc Health Risk Manag 2012;8:1–6.
  • Vázquez BY, Vázquez MA, Jáquez MG, et al. Blood pressure directly correlates with blood viscosity in diabetes type 1 children but not in normal. Clin Hemorheol Microcirc 2010;44:55–61.
  • Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: A disease of the microcirculation? Hypertension 2006;48:1012–17.
  • Fujishima M, Ibayashi S, Fujii K, Mori S. Cerebral blood flow and brain function in hypertension. Hypertens Res 1995;18:111–17.
  • Battegay EJ, De Miguel LS, Petrimpol M, Humar R. Effects of anti-hypertensive drugs on vessel rarefaction. Curr Opin Pharmacol 2007;7:151–57.
  • Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 1984;6:408–19.
  • Wang B, Li BW, Li HW, et al. Enhanced matrix metalloproteinases-2 activates aortic endothelial hypermeability, apoptosis and vascular rarefaction in spontaneously hypertensive rat. Clin Hemorheol Microcirc 2014;57:325–38.
  • Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 2013;304:H1598–1614.
  • Sokolova IA, Manukhina EB, Blinkov SM, et al. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. Microvasc Res 1985;30:1–9.
  • Fugler LA, Eades SC, Moore RM, et al. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors. Am J Vet Res 2013;74:473–80.
  • Kobayashi N, DeLano FA, Schmid-Schönbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 2005;25:2114–21.
  • Bruno Rde B, Marques TF, Batista TM, et al. Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia. Brain Res 2009;13(1260):55–64.
  • Sloop G, Holsworth RE Jr, Weidman JJ, St Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther Adv Cardiovasc Dis 2015;9:19–25.
  • Plotnikov MB, Aliev OI, Anishchenko AM, et al. Parameters of cerebral cortex capillary network in SHR rats during the development of arterial hypertension and stable high blood pressure. Fiziol Zh Im I M Sechenova 2016;102:558–66. ( Article in Russian).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.